Lung Cancer News and Research

Latest Lung Cancer News and Research

Cancer patients require better treatment for depression

Findings from three research studies have shown that around three quarters of cancer patients who suffer from major depression do not receive treatment for their depression and that a newly developed medical programme has proven more effective than standard care at reducing depression in these patients.

28 Aug 2014

Widespread awareness, better treatment lower prostate cancer death rates

Fewer men are being diagnosed with and dying from prostate cancer these days. While that is due in part to widespread awareness and better treatment, it is also the result of more judicious screening.

28 Aug 2014

Scientists explore ways to personalise radiotherapy dose given to lung cancer patients

Manchester scientists are working out how to safely increase the radiotherapy dose given to lung cancer patients - potentially offering improved local control and survival.

From The University of Manchester 28 Aug 2014

Advanced statistical approach evaluates gene-environmental interactions that contribute to disease

Dartmouth cancer researchers developed and tested an advanced statistical model to evaluate the genetic and environmental interactions that contribute to disease as published yesterday in Human Genetics.

28 Aug 2014

Asterias receives clearance from FDA to initiate Phase 1/2a clinical trial of AST-OPC1

Asterias Biotherapeutics Inc. has received clearance from the U.S. Food and Drug Administration to initiate a Phase 1/2a clinical trial of its product, AST-OPC1, in patients with complete cervical spinal cord injury.

27 Aug 2014

Research to determine breath test's effectivness in patient with COPD

NYU Langone Medical Center will lead a new clinical initiative -- funded by a $225,000 grant from The National Institutes of Health -- to determine a breath test's effectivness to identify volatile organic compounds (VOCs) in human breath that are biomarkers of chronic obstrutive pulmonary disease (COPD).

26 Aug 2014

Loyola’s free prostate cancer screenings on September 17

As part of Prostate Cancer Awareness Month, Loyola University Medical Center will offer free prostate cancer screenings on Wednesday, Sept. 17.

26 Aug 2014

Current x-ray- examinations capture only 20% of lung cancer cases

Each year, nearly 3000 Norwegians develop lung cancer. Current x-ray- examinations capture only 20 percent of cases. With modern ultralow-dose CT, the radiologists hit the bull's eye 90 per cent of the time.

26 Aug 2014

Spring Bioscience launches PD-L1 (SP142) rabbit monoclonal immunohistochemistry antibody1

Spring Bioscience (Spring), a member of the Roche Group, today announced the launch of its PD-L1 (SP142) rabbit monoclonal immunohistochemistry (IHC) antibody.

25 Aug 2014

Researchers examine impact of BIM deletion on survival outcomes of advanced NSCLC patients

Bcl-2-like protein 11 (BIM) deletion in advanced non-small cell lung cancer (NSCLC) is associated with shorter progression free survival (PFS) in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) or chemotherapy treated Asian patients.

25 Aug 2014

Pre-op PET/CT predicts stage I NSCLC adjuvant chemotherapy benefit

Preoperative imaging could help guide the use of postoperative adjuvant chemotherapy in patients with early non-small-cell lung cancer, Japanese researchers believe.

21 Aug 2014

Erlotinib feasible in KRAS wild-type lung adenocarcinoma

Erlotinib is a valid treatment option for patients with KRAS wild-type lung adenocarcinoma refractory to chemotherapy, study data show.

21 Aug 2014

Researchers identify mutated forms of gene that encodes unregulated enzyme driving CML

Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have identified and characterized mutated forms of the gene that encodes BCR-ABL, the unregulated enzyme driving the blood cancer chronic myeloid leukemia (CML).

21 Aug 2014

EGFR biomarkers predict NSCLC response to vandetanib

Biomarker analyses of tumour samples from the ZODIAC study indicate that epidermal growth factor receptor gene copy number and mutation status may help identify the non-small-cell lung cancer patients most likely to benefit from treatment with vandetanib plus docetaxel.

20 Aug 2014

Lung Cancer Alliance praises NCI's new ALCHEMIST trial

Lung Cancer Alliance (LCA) President & CEO, Laurie Fenton Ambrose praised the National Cancer Institute's (NCI) new trial, launched today, that will focus on the prevention of recurrence in two specific types of lung cancers when they are caught at early stage and surgically removed.

19 Aug 2014

Microbes influence human eating behavior, dietary choices

It sounds like science fiction, but it seems that bacteria within us — which outnumber our own cells about 100-fold — may very well be affecting both our cravings and moods to get us to eat what they want, and often are driving us toward obesity.

17 Aug 2014

Study finds link between common respiratory diseases and increased risk of lung cancer

Links between a number of common respiratory diseases and an increased risk of developing lung cancer have been found in a large pooled analysis of seven studies involving more than 25,000 individuals.

16 Aug 2014

Diet reduces inflammatory markers in ‘real world’ Type 2 diabetes

Encouraging patients newly diagnosed with Type 2 diabetes to diet or to diet and increase their physical activity reduces markers of inflammation and their cardiovascular risk compared with usual care, real-world study findings show.

15 Aug 2014

Research offers promise for personalized RNA combination therapies to treat lung cancer

Small RNA molecules, including microRNAs (miRNAs) and small interfering RNAs (siRNAs), offer tremendous potential for new therapeutic agents to inhibit cancer cell growth. However, delivering these small RNAs to solid tumors remains a significant challenge, as the RNAs must target the correct cells and avoid being broken down by enzymes in the body.

15 Aug 2014

Clinical trial tests COXEN model in bladder cancer to find promising treatment

Imagine being able to match a cancer's genes to the best treatment. That's the promise of COXEN (CO eXpression ExtrapolatioN) - a computer program that looks at a panel of cancer genes in a patient's tumor to predict whether it will respond to chemotherapy.

14 Aug 2014

Lung Cancer News and Research

Latest Lung Cancer News and Research

Cancer patients require better treatment for depression

Widespread awareness, better treatment lower prostate cancer death rates

Scientists explore ways to personalise radiotherapy dose given to lung cancer patients

Advanced statistical approach evaluates gene-environmental interactions that contribute to disease

Asterias receives clearance from FDA to initiate Phase 1/2a clinical trial of AST-OPC1

Research to determine breath test's effectivness in patient with COPD

Loyola’s free prostate cancer screenings on September 17

Current x-ray- examinations capture only 20% of lung cancer cases

Spring Bioscience launches PD-L1 (SP142) rabbit monoclonal immunohistochemistry antibody1

Researchers examine impact of BIM deletion on survival outcomes of advanced NSCLC patients

Pre-op PET/CT predicts stage I NSCLC adjuvant chemotherapy benefit

Erlotinib feasible in KRAS wild-type lung adenocarcinoma

Researchers identify mutated forms of gene that encodes unregulated enzyme driving CML

EGFR biomarkers predict NSCLC response to vandetanib

Lung Cancer Alliance praises NCI's new ALCHEMIST trial

Microbes influence human eating behavior, dietary choices

Study finds link between common respiratory diseases and increased risk of lung cancer

Diet reduces inflammatory markers in ‘real world’ Type 2 diabetes

Research offers promise for personalized RNA combination therapies to treat lung cancer

Clinical trial tests COXEN model in bladder cancer to find promising treatment

The ultimate guide to lung research tools and protocols eBook

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Newsletters you may be interested in